<?xml version="1.0" encoding="UTF-8"?>
<p>Most of the information available on the toxicity of furocumarins in humans is from studies with patients suffering from skin diseases, such as vitiligo or psoriasis. SKLM (
 <xref rid="efs26548-bib-0069" ref-type="ref">2006</xref>) reports on therapeutic oral doses in the treatment of psoriasis in the range of 0.5–0.6 mg 8‐MOP/kg bw or 1.2 mg 5‐MOP/kg bw administered in combination with UVA (0.5–7 J/cm
 <sup>2</sup>, wavelength range 315–400 nm, maximum at 355 nm).
</p>
